"At Ionis, each of us comes to work every day with a singular mission: discovering novel and innovative therapies that can create futures for the sick people who depend on us. We are proud to be recognized by CLSA as company of the year, and we look forward to continuing to set an example for the life sciences industry here in California and around the world," said Stanley T. Crooke, M.D., Ph.D., chairman and chief executive officer of Ionis.